Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rosaria Amoroso

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Gynecologic Oncology|November 28, 2009
Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapyMatteo Landriscina, Maria Rosaria Amoroso, Annamaria Piscazzi, et al.
American Journal of Cancer Research|March 21, 2012
New insights into TRAP1 pathwayDanilo Swann Matassa, Maria Rosaria Amoroso, Francesca Maddalena, et al.
International Journal of Oncology|July 4, 2014
TRAP1 revisited: novel localizations and functions of a 'next-generation' biomarker (review)Maria Rosaria Amoroso, Danilo Swann Matassa, Lorenza Sisinni, et al.
Advances in Protein Chemistry and Structural Biology|April 22, 2017
Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven InflammationMaria Rosaria Amoroso, Danilo Swann Matassa, Ilenia Agliarulo, et al.
FEBS Letters|February 1, 2011
The ribonuclease/angiogenin inhibitor is also present in mitochondria and nucleiAdriana Furia, Marco Moscato, Gaetano Calì, et al.
Oncotarget|June 19, 2015
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinomaValentina Condelli, Francesca Maddalena, Lorenza Sisinni, et al.
Molecular Oncology|June 6, 2013
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1Francesca Maddalena, Lorenza Sisinni, Giacomo Lettini, et al.
Cancer Research|July 22, 2010
Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agentsMatteo Landriscina, Gabriella Laudiero, Francesca Maddalena, et al.
Neurotoxicology|May 21, 2026
Ozone in Neurodegeneration: An Environmental Toxicant or a Therapeutic Hormetin?Caterina Vinciguerra, Mariangela Cernera, Marika Comegna, et al.
Cancer Research|September 21, 2014
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumorsValentina Condelli, Annamaria Piscazzi, Lorenza Sisinni, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology|November 28, 2009
Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapyMatteo Landriscina, Maria Rosaria Amoroso, Annamaria Piscazzi, et al.
American Journal of Cancer Research|March 21, 2012
New insights into TRAP1 pathwayDanilo Swann Matassa, Maria Rosaria Amoroso, Francesca Maddalena, et al.
International Journal of Oncology|July 4, 2014
TRAP1 revisited: novel localizations and functions of a 'next-generation' biomarker (review)Maria Rosaria Amoroso, Danilo Swann Matassa, Lorenza Sisinni, et al.
Advances in Protein Chemistry and Structural Biology|April 22, 2017
Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven InflammationMaria Rosaria Amoroso, Danilo Swann Matassa, Ilenia Agliarulo, et al.
FEBS Letters|February 1, 2011
The ribonuclease/angiogenin inhibitor is also present in mitochondria and nucleiAdriana Furia, Marco Moscato, Gaetano Calì, et al.
Oncotarget|June 19, 2015
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinomaValentina Condelli, Francesca Maddalena, Lorenza Sisinni, et al.
Molecular Oncology|June 6, 2013
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1Francesca Maddalena, Lorenza Sisinni, Giacomo Lettini, et al.
Cancer Research|July 22, 2010
Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agentsMatteo Landriscina, Gabriella Laudiero, Francesca Maddalena, et al.
Neurotoxicology|May 21, 2026
Ozone in Neurodegeneration: An Environmental Toxicant or a Therapeutic Hormetin?Caterina Vinciguerra, Mariangela Cernera, Marika Comegna, et al.
Cancer Research|September 21, 2014
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumorsValentina Condelli, Annamaria Piscazzi, Lorenza Sisinni, et al.
Pageof 2